WHC is still in active development. Read this to understand our approach.
depiction of ZRSNZINYAWTAHE-UHFFFAOYSA-N.svg
isomerdesign

4-MBAL

Check on isomerdesign

pubchem

4-Methoxybenzaldehyd...

Check on pubchem

drugmap

4-Methoxybenzaldehyd...

Check on drugmap

Data

InChI: InChI=1S/C8H8O2/c1-10-8-4-2-7(6-9)3-5-8/h2-6H,1H3

Synonyms: Aubepine,P-METHOXYBENZALDEHYDE [FHFI],CHEBI:28235,EINECS 256-891-3,p-Anisaldehyde, 8CI,Obepin,BRN 0471382,Methoxybenzaldehyde (Related),AC7808,p-Methoxybenzylidenemalonitrile,CAS-123-11-5,EINECS 204-602-6,F2190-0575,para-methoxybenzaldehyde,NCGC00090807-02,4-methoxybenzylaldehyde,CS-W020189,AKOS000118814,4-MBAL,DSSTox_RID_78277,SMR001224521,p-Anisaldehyde, >=97.5%, FCC, FG,anisaldehyd,A805017,4-methoxybezaldehyde,EC 204-602-6,p-Anisaldehyde, analytical standard,AI3-00223,p-Anisaldehyde, 98%,A0480,MFCD00003385,P-Anisaldehyde,(S),AC-10379,4-08-00-00252 (Beilstein Handbook Reference),CHEMBL161598,Tox21_303331,p-Anisaldehyde,Anisic aldehyde,SY001689,p-Methoxybenzaldehyde,CS-11005,68894-36-0,FT-0617622,ZINC157146,p-Formylanisole,Anisaldehyde solution,p-Anisaldehyde, certified reference material, TraceCERT(R),NSC5590,DTXSID2026997,anisal,Formylanisole, p-,EN300-16096,p-Anisaldehyde, primary pharmaceutical reference standard,Caswell No. 051E,HY-Y0740,HMS3039F08,50984-52-6,p-Anisaldehyde, Reagent,PARA- METHOXYBENZALDEHYDE,para-methoxy benzaldehyde,4-Methoxybenzaldehyde,para-anisaldehyde,Crategine,Benzaldehyde, 4-methoxy-,ANISALDEHYDE [INCI],4-Anisaldehyde,4-(methyloxy)benzaldehyde,FT-0662228,MLS002152921,bmse010130,P-ANISALDEHYDE,Q-100105,P-ANISALDEHYDE [HSDB],4-methoxybenzene carboxaldehyde,P-METHOXYBENZALDEHYDE [FCC],WLN: VHR DO1,FEMA 2670,STL194068,p-methoxy benzaldehyde,Z53833125,NCGC00257076-01,4-methoxybenzaldehye,BDBM50139370,NSC-5590,s5086,DSSTox_CID_6997,SCHEMBL1100,P-ANISALDEHYDE [USP-RS],Anisaldehyde (para),DB-012818,BENZALDEHYDE,4-METHOXY MFC8 H8 O2,UNII-9PA5V6656V,4-methoxylbenzaldehyde,NCGC00090807-01,123-11-5,4-Methoxy-benzaldehyde,CCRIS 821,9PA5V6656V,Anis aldehyde,NSC 5590,Tox21_201943,p-Methoxybenzaldehyde (natural),P-ANISALDEHYDE [MI],FT-0662227,DSSTox_GSID_26997,p-Methoxy Benzaldehyde, Natural,Q174937,4-methoxy benzaldehyde,FEMA No. 2670,p-anisaldehyde solution,CCG-214805,3-Chlorobenzenesulfonyl chloride, 98%,p-Anisic aldehyde,NATURAL ANISIC ALDEHYDE,p-Anisaldehyde, natural, 98%, FG,p-Anisaldehyde, for synthesis, 98.0%,HSDB 2641,Anisaldehyde,p-Anisaldehyde,p-Methoxybenzaldhyde,NCGC00259492-01,p-Anisaldehyde, United States Pharmacopeia (USP) Reference Standard,MEPYRAMINE MALEATE IMPURITY P [EP IMPURITY]

Estimated data

Solubility: -1.361 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 57.9% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.